MDB Capital Holdings Year-End Update

Rhea-AI Summary

MDB Capital Holdings, (NASDAQ: MDBH) reported its fourth quarter and full year 2023 results, highlighting recent corporate progress. The company launched PV Trade, a trading platform for public venture equities, enhanced its brokerage services, secured additional funding for its subsidiary Invizyne Technologies Inc., and filed for an IPO. CEO Christopher Marlett will host a Zoom webinar today to discuss recent developments and future milestones.

Positive

• MDB launched PV Trade, a trading platform for public venture equities, to provide seamless online trading and enhance liquidity.
• The company added self-directed IRA capabilities and a money-market option to its brokerage services.
• MDB secured additional non-dilutive funding for its subsidiary Invizyne Technologies Inc. and filed for an IPO.
• CEO Christopher Marlett will host a Zoom webinar today to discuss recent developments, ongoing initiatives, and anticipated 2024 milestones.

Negative

• None.

Insights

Financial Analyst

MDB Capital Holdings, with its recent IPO, underscores the significance of its transition to a self-clearing broker dealer. This strategic move may enhance operational efficiencies and reduce reliance on third-party clearing services, potentially translating into improved margins. The expansion into self-directed IRAs and a competitive money-market offering reflects a targeted approach to attract investors who prefer a hands-on investment strategy, while also seeking the stability offered by money-market funds. Investors should be attentive to the firm’s ability to scale these services without incurring prohibitive costs. The progress of portfolio company Invizyne Technologies, particularly its IPO filing, could indicate MDB's capability to identify and nurture 'Big Ideas'. However, the timing of the IPO and the market reception will be pivotal. The preference for MDB Class A shareholders in the IPO allocation suggests an emphasis on internal investor relations, yet the potential dilution effect should be monitored.

Biotech Industry Analyst

The non-dilutive funding received by Invizyne from BETO and GCxN underscores the strategic public-private partnerships that can propel companies in the biotech space. Non-dilutive funding is often a boon for such companies as it supports R&D without impacting equity stakes. Additionally, the upcoming IPO represents a critical liquidity event and a validation of Invizyne's technology and market potential. However, the nature of enzyme-based biomanufacturing systems is complex and investors should weigh the scientific viability, regulatory landscape and competitive positioning of Invizyne. The industry's fast pace means that Invizyne must continuously innovate to maintain its leading designer status in the sector.

Market Research Analyst

MDB's integrated IP solution platform, PatentVest, could be instrumental in strengthening its competitive edge. Intellectual property is the linchpin of value creation in deep technology ventures and a robust IP management tool can attract innovative companies seeking to protect and capitalize on their inventions. The ability to review a higher volume of technology ideas and finance them is indicative of MDB's commitment to growth, but the real test lies in the consistent quality of those ideas and their commercial viability. Investors should also note the implications of a proprietary trading platform like PV Trade, which offers potential benefits of liquidity and value but requires strict compliance and transparency to foster investor confidence.

Management to Host Zoom Webinar Today at 4:30 p.m. ET

Addison, Texas, April 17, 2024 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ: MDBH) (“MDB”), a public venture platform focused on launching category-leading deep technology companies, reported results for its fourth quarter and full year ended December 31, 2023, on form 10-K filed with the Securities and Exchange Commission, and will highlight recent corporate progress on today’s call with management.

“On the heels of completing our IPO on the NASDAQ in the third quarter of 2023, we’ve been working diligently to advance our self-clearing broker dealer capabilities to support our investor community, increasing the number of deep technology ideas we review and ultimately finance, as well as ramp up the number of clients engaged with our integrated IP solution platform, PatentVest, which is critical in assisting the companies we back to become leaders in their technology category,” said Christopher Marlett, CEO and Co-Founder of MDB. “I look forward to providing an update on today’s webinar to help shareholders understand how to measure our performance as we begin to transform more ‘Big Ideas’ into valuable public companies and in turn, demonstrate why we believe public venture outperforms traditional venture-stage investing.”

Fourth Quarter 2023 and Subsequent Operational Highlights

• Launched PV Trade, our dedicated trading platform for public venture equities: PV Trade enables seamless online trading via mobile device or desktop applications and is coupled with a professional trading team dedicated to providing value and liquidity through constant attention to orders for early-stage public companies.
• Bolstered brokerage offering with addition of self-directed IRA capabilities and competitive money-market option: Following final regulatory approval for Public Ventures to act as a self-clearing broker-dealer, the company enhanced its brokerage services with the addition of an Invesco Money Market fund option and a self-directed IRA platform through Strata Trust, which enables private, public, and alternative investments. The additions are all part of the company’s mission to provide an exclusive clearing and trading platform to make it easier to invest in public venture.
• Secured additional non-dilutive funding and filed S-1 for IPO of “Big Idea” partner company: At the beginning of the quarter, Invizyne Technologies Inc. (“Invizyne”), a leading designer of enzyme-based biomanufacturing systems – and a subsidiary of MDB – was awarded $3.77 million in additional funding from the Bioenergy Technologies Office (BETO) within the U.S. Department of Energy's (DOE's) Office of Energy Efficiency and Renewable Energy (EERE) and $250,000 to participate in the latest Shell Gamechanger Accelerator™ Powered by NREL (GCxN) program. In February 2024, Invizyne filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission for the sale of its common stock in a firm commitment public offering. The company anticipates the IPO will occur in late Q2 to early Q3, with timing subject to SEC review process. In allocating the shares to be sold in IPO, the company intends to give preference to holders of MDB Class A Shares.

Fourth Quarter and Fiscal 2023 Results Zoom Webinar at 4:30 p.m. ET Today

Christopher Marlett, CEO and Co-Founder of MDB will lead the webinar and will be joined by other members of the management team to review recent developments, ongoing initiatives, anticipated 2024 milestones, as well as host a question-and-answer period.

Investors can register for the Zoom webinar here. The live webinar can also be accessed on MDB's investor relations website at https://investors.mdb.com/.

About MDB Capital Holdings, LLC

MDB was founded in 1997 with the purpose of backing visionary technology, inventors, and technology entrepreneurs via a new form of public venture capital that finances pre-revenue, early-stage companies through early public offerings, primarily listed on NASDAQ. After successfully launching 16 companies under this public venture model, MDB itself became a public entity to attract investors who share its vision to continue to launch new platform technologies into the public markets.

MDB currently has two wholly owned subsidiaries, Public Ventures, LLC ("Public Ventures'') and Patentvest, Inc., and has a majority ownership stake in Invizyne Technologies, Inc. MDB recently expanded the business scope of Public Ventures, an SEC registered and FINRA member broker dealer, to include self-clearing capabilities to enhance its investment banking services to both issuers and investors.

For more information, please visit www.mdb.com.

Forward-Looking Statements

This press release contains "forward-looking statements." These forward-looking statements are made as of the date they were first issued and were based on current expectations, estimates, forecasts and projections as well as the beliefs and assumptions of management. Words such as "expect," "anticipate," "should," "believe," "hope," "target," "project," "goals," "estimate," "potential," "predict," "may," "will," "might," "could," "intend," "shall" and variations of these terms or the negative of these terms and similar expressions are intended to identify these forward-looking statements.

Forward-looking statements are subject to a number of risks and uncertainties, many of which involve factors or circumstances that are beyond MDB's control. MDB's actual results could differ materially from those stated or implied in forward-looking statements due to a number of factors, including but not limited to, risks detailed in documents that may be filed by MDB from time to time with the SEC. The forward-looking statements included in this press release represent MDB's views as of the date of this press release. MDB anticipates that subsequent events and developments will cause its views to change. MDB undertakes no intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. These forward-looking statements should not be relied upon as representing MDB's views as of any date subsequent to the date of this press release.

Investor Relations Contact:
IR@mdb.com

Media Contact:
press@mdb.com

FAQ

What are the highlights of MDB Capital Holdings' fourth quarter and full year 2023 results?

MDB Capital Holdings reported its fourth quarter and full year 2023 results, showcasing corporate progress and achievements.

What is PV Trade and how does it benefit public venture equities?

PV Trade is a trading platform launched by MDB for public venture equities, providing seamless online trading and enhanced liquidity.

What additional services did MDB add to its brokerage offering?

MDB added self-directed IRA capabilities and a money-market option to its brokerage services.

How did MDB secure funding for its subsidiary Invizyne Technologies Inc.?

MDB secured additional non-dilutive funding for its subsidiary Invizyne Technologies Inc. and filed for an IPO.

Who will lead the Zoom webinar today and what will be discussed?

CEO Christopher Marlett will lead the Zoom webinar to discuss recent developments, ongoing initiatives, and anticipated 2024 milestones.